Verve Ventures interview with CEO Karsten Lindhardt
Interview Karsten Lindhardt: “We are uniquely positioned to succeed” (verve.vc) The use of injections in treatments is widespread, but their use can […]
Category: News
Press Release: Biograil and CSL Sign Collaboration Agreement for development of certain CSL compounds using Biograil’s proprietary BIONDD™ technology.
COPENHAGEN, DENMARK, July 17th, 2024 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]
Biograil presents at TIDES USA
On Friday May 17th, 2024, CTO Nikolaj Skak had the pleasure to present the BIONDD™ technology at the TIDES USA Conference in Boston. Great […]
Presentation of student project “Assessment of barriers towards oral treatment of autoimmune diseases with adalimumab”
I am happy to share that, I have finalized my project “Assessment of barriers towards oral treatment of autoimmune diseases with adalimumab” […]
Biograil presents at CEO & Investor Conference in New York City
On February 27th 2024, Karsten Lindhardt CEO and founder of Biograil had the pleasure of presenting the BIONDD™ technology to an exclusive audience at […]
Biograil CTO and Industrial Postdoc present at APPSComms PharmsSci 360
CTO Nikolaj Skak and Industrial Postdoc Nina Mertz attended the APPSComms PharmsSci 360 October 22-25, 2023, in Orlando, FL. It was great […]
Press Release: Biograil and Lilly Sign Collaboration and License Agreement
COPENHAGEN, DENMARK, October 4th, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]
Press Release: Biograil Receives Innobooster Grant Providing Non-dilutive funding for BIONDD™ in Preparations for Phase 1 clinical trials
COPENHAGEN, DENMARK, 14 March, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics […]
Press Release: Biograil Forms International Scientific Advisory Board
COPENHAGEN, DENMARK, March 1st, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics […]
Press Release: Biograil signs collaboration agreement with Janssen
COPENHAGEN, DENMARK, December 2nd, 2020 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]